Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications

NCT06573008 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

328

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

DRUG: GP681 40mg
DRUG: GP681 Simulant

Sponsor

Jiangxi Qingfeng Pharmaceutical Co. Ltd.